140 related articles for article (PubMed ID: 26596836)
1. High expression of FOXR2 in breast cancer correlates with poor prognosis.
Song H; He W; Huang X; Zhang H; Huang T
Tumour Biol; 2016 May; 37(5):5991-7. PubMed ID: 26596836
[TBL] [Abstract][Full Text] [Related]
2. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A
BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis.
Song H; Liu C; Shen N; Yi P; Dong F; Li X; Zhang N; Huang T
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):113-119. PubMed ID: 27258563
[TBL] [Abstract][Full Text] [Related]
4. FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma.
Wang X; He B; Gao Y; Li Y
Tumour Biol; 2016 Aug; 37(8):10459-67. PubMed ID: 26846213
[TBL] [Abstract][Full Text] [Related]
5. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
6. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
7. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
[TBL] [Abstract][Full Text] [Related]
8. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
9. Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer.
Li B; Huang W; Cao N; Lou G
J Cell Biochem; 2018 Sep; 119(9):7780-7789. PubMed ID: 29943836
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
11. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
13. Foxo3a expression is a prognostic marker in breast cancer.
Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
Zhang Z; Meng G; Wang L; Ma Y; Guan Z
Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
[TBL] [Abstract][Full Text] [Related]
17. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype.
Zhao H; Tang H; Xiao Q; He M; Zhao L; Fu Y; Wu H; Yu Z; Jiang Q; Yan Y; Jin F; Wei M
Mol Med Rep; 2016 Dec; 14(6):5261-5270. PubMed ID: 27779682
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
Endo Y; Yamashita H; Takahashi S; Sato S; Yoshimoto N; Asano T; Hato Y; Dong Y; Fujii Y; Toyama T
BMC Cancer; 2014 Dec; 14():990. PubMed ID: 25528056
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
20. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
